Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-07-16
1996-05-21
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514826, A61K 31335
Patent
active
055190499
ABSTRACT:
Compositions comprising certain macrolides are disclosed which are useful in methods for the treatment of reversible obstructive airway diseases, particularly asthma.
REFERENCES:
Martindale, The Extra Pharmacopoeia, 28th ed. (1982) pp. 1445-1448.
Volk, Wesley A., Essentials of Medical Microbiology, 2nd edition (1982) pp. 202-203.
Remington's Pharmaceutical Sciences pp. 1314 and 1315, 17th Ed., 1985.
Sandoz "Azatricyclooctacosane . . . " Chem Abst 112(13):112071m (1989).
Merck Manual pp. 615, 627, 1982.
Remington's p. 1706, 1990.
Current Therapy, pp. 147-148, 1992.
Akutsu Ikuo
Fukuda Takeshi
Jackson Dale M.
Makino Sohei
Norris Alan A.
Fisons plc
Fujisawa Pharmaceutical Company Limited
Henley III Raymond
LandOfFree
Macrolides for the treatment of reversible obstructive airways d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrolides for the treatment of reversible obstructive airways d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrolides for the treatment of reversible obstructive airways d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038382